SANTEN PHARMACEUTICAL CO - stock earnings
4536.T Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 29.0 million JPY | 79.1 billion JPY |
| 2023Q4 | 7.3 billion JPY | 77.0 billion JPY |
| 2023Q3 | 8.9 billion JPY | 73.4 billion JPY |
| 2023Q2 | 10.4 billion JPY | 72.4 billion JPY |
| 2022Q4 | 6.0 billion JPY | 70.9 billion JPY |
| 2022Q3 | -28.7 billion JPY | 63.4 billion JPY |
| 2022Q2 | 6.7 billion JPY | 65.5 billion JPY |
4536.T Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 26.6 billion JPY | 302.0 billion JPY |
| 2023 | -14.9 billion JPY | 279.0 billion JPY |
| 2022 | 27.2 billion JPY | 266.3 billion JPY |
| 2021 | 6.8 billion JPY | 249.6 billion JPY |
| 2020 | 23.6 billion JPY | 241.6 billion JPY |
4536.T
Price: ¥1,598
Dividend Yield: 0.02%
Forward Dividend Yield: 2.13%
Payout Ratio: 45.56%
Dividend Per Share: 34.00 JPY
Earnings Per Share: 74.62 JPY
P/E Ratio: 21.96
Exchange: JPX
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 555.4 billion
Average Dividend Frequency: 2
Years Paying Dividends: 24
DGR3: 6.00%
DGR5: 4.37%
DGR10: 4.95%
DGR20: 12.47%